Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-043547

Director acquired 2,145 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aliski William · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-24 Grant or award : show line 1 in the form +2,145 66,849 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-24 Grant or award : show line 2 in the form Stock Option (Right to Buy) +4,125 4,125 D
Loading xslF345X03/doc4.xml…